Person

Chad Winters

VP, Chief Accounting Officer, West Pharmaceutical Services

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$915K

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Apr 27, 2026WSTSale896$300.67$269K
Mar 11, 2024WSTSale815$358.82$292K
Dec 1, 2023WSTSale1,013$349.00$354K

SEC reporting-owner ID (CIK) 1811424 · all filings on EDGAR

Chad Winters (WST) | USBoard